1988
DOI: 10.1016/0003-9861(88)90616-9
|View full text |Cite
|
Sign up to set email alerts
|

Oxidative decarboxylation of salsolinol-1-carboxylic acid to 1,2-dehydrosalsolinol: Evidence for exclusive catalysis by particulate factors in rat kidney

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

1989
1989
2014
2014

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…The significance of these higher (hypothalamic) concentrations early in the EtOH regimen remains to be determined. Initial hypothalamic mechanisms that regulate drinking (Amit and Stern, 197 1;Meyers et al, 1985) might be affected by the sTIQs, or the sTIQs may serve to initiate some aspect of neuronal degeneration, possibly, in the 1-carboxylated cases, via formation of 3,4-dihydroisoquinolines (Collins and Cheng, 1988). However, it is difficult to envision the sTIQs as part of a general ongoing mechanism of damage as originally postulated (Collins, 1982), because their concentrations were not significantly increased in the striatum, where nerve terminal loss occurred after EtOH ingestion for nearly 6 months, or in the circulation at either exposure time.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The significance of these higher (hypothalamic) concentrations early in the EtOH regimen remains to be determined. Initial hypothalamic mechanisms that regulate drinking (Amit and Stern, 197 1;Meyers et al, 1985) might be affected by the sTIQs, or the sTIQs may serve to initiate some aspect of neuronal degeneration, possibly, in the 1-carboxylated cases, via formation of 3,4-dihydroisoquinolines (Collins and Cheng, 1988). However, it is difficult to envision the sTIQs as part of a general ongoing mechanism of damage as originally postulated (Collins, 1982), because their concentrations were not significantly increased in the striatum, where nerve terminal loss occurred after EtOH ingestion for nearly 6 months, or in the circulation at either exposure time.…”
Section: Discussionmentioning
confidence: 99%
“…For HPLC, aliquots (1 0-20 pl) of the acid supernatants were removed, 3,4-dihydroxybenzylamine (DHBA, internal standard) was added, and the sample was diluted for quantitation of DA, serotonin (5-HT), and their acid metabolites. The reversed phase HPLC system and conditions were described previously by Cheng et al (1987) and Collins and Cheng ( 1988). Aliquots also were taken for protein determination according to Lowry et al (1951).…”
Section: Methodsmentioning
confidence: 99%
“…Traces of 1-methyl-3,4-dihydro-6,7-isoquinolinediol (1,2-dehydroSal) have been found in extracts of human brain (Ung-Chhun et al, 1985), but the compound could have resulted from 1-carboxy-Sal as an artefact due to air oxidation after death. Decarboxylation of 1-carboxy-Sal by incubation with rat tissues, including brain, was found to result in the formation of 1,2-dehydroSal only (Collins and Cheng, 1988). No Sal was detected, even with added NADPH.…”
Section: Discussionmentioning
confidence: 93%
“…The fact that salsolinol was not found in urine of subject 1 after administration of Madopar shows that there is no alternative pathway for salsolinol formation in humans, and also that salsolinol does not derive from direct decarboxylation of 1-carboxy-salsolinol. The inability of subject 1 to reduce 1,2-dehydrosalsolinol has to be considered with regard to the recent results reported by Collins and Cheng (1988), who found that incubation of 1-carboxy-salsolinol with rat liver or whole brain homogenates led to the formation of 1,2-dehydrosalsolinol only; no traces of salsolinol were found, even with added NADPH. 1,2-Dehydrosalsolinol has been reported to be a potent inhibitor of catechol-O-methyltransferase (Cheng et al, 1987) Its increased formation after administration of Madopar might contribute to the beneficial effects of L-dopa therapy by inhibiting one of the catabolic pathways of DA.…”
Section: Discussionmentioning
confidence: 99%